Enablex

Active Ingredient(s): Darifenacin
FDA Approved: * December 22, 2004
Pharm Company: * NOVARTIS
Category: Urinary System

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Enablex Overview

Darifenacin (trade name Enablex in US and Canada, Emselex in Europe) is a medication used to treat urinary incontinence. It was discovered by scientists at the Pfizer research site in Sandwich, UK under the identifier UK-88,525 and used to be marketed by Novartis. In 2010 the US rights were sold to Warner Chilcott for 400 million US$. Contents 1 Adverse effects 2 Medical uses 3 Mechanism of action 4 References 5 External links Adverse effects Ddarifenacin should not be used in people...

Read more Enablex Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Darifenacin

Recent Enablex Forums:

Possible Dosages for this and Related Drugs:

NDC Database Records for Enablex: (7 results)

Sorted by National Drug Code

• 0078-0419 24 Hr Enablex 7.5 mg Extended Release Tablet by Novartis Pharmaceuticals Corporation
• 0078-0420 Enablex 15 mg 24 Hr Extended Release Tablet by Novartis Pharmaceuticals Corporation
• 0430-0170 24 Hr Enablex 7.5 mg Extended Release Tablet by Warner Chilcott (Us), LLC
• 0430-0171 Enablex 15 mg 24 Hr Extended Release Tablet by Warner Chilcott (Us), LLC
• 35356-272 Enablex 15 mg 24 Hr Extended Release Tablet by Lake Erie Medical & Surgical Supply Dba Quality Care Products LLC
• 54868-5363 Enablex 15 mg 24 Hr Extended Release Tablet by Physicians Total Care, Inc.
• 54868-5704 24 Hr Enablex 7.5 mg Extended Release Tablet by Physicians Total Care, Inc.

Other drugs which contain Darifenacin or a similar ingredient: (1 result)

• DARIFENACIN

Related Enablex Topics: